QNCX (STOCKS)
Quince Therapeutics, Inc. Common Stock
$32.500000
+1.240000 (+3.97%)
Prev close: $31.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Dirk Thye
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $42.14M
- Employees
- 36
- P/E (TTM)
- -0.18
- P/B (TTM)
- 1.38
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$57.60 | $-52.22 | +109.8240 | +210.29% |
|
Dec 2025 (Q4)
|
$-142.00 | $-38.52 | -103.4848 | -268.69% |
|
Sep 2025 (Q3)
|
$-50.00 | $-44.15 | -5.8544 | -13.26% |
|
Jun 2025 (Q2)
|
$-46.00 | $-51.34 | +5.3407 | +10.40% |